Search and Filter
Results per Page:
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Crunching the numbers for next-gen COVID-19 vaccines
BARDA taps Fred Hutch biostatisticians to assess new vaccine technology, more nimble trial design
Getting a paw up in the cat-and-mouse game with the COVID-19 virus
Fred Hutch researchers invent method to quickly and safely test thousands of mutations to predict which ones could help the virus escape our defenses
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses
On World AIDS Day, a broad view of continuing work
Teams of Fred Hutch scientists test vaccines, treatments, new strategies
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
Team of top researchers prepares for endemic COVID-19
$15M Howard Hughes Medical Institute grant shared by 8 scientists at Fred Hutch and UW
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Science Says: Fearless science
Immunotherapy, equity in colorectal cancer and the latest on the COVID-19 virus's omicron variant
Researchers pinpoint 'correlates of protection' for Moderna vaccine
Findings may make it easier to test COVID-19 vaccine updates to protect against variants
Fred Hutch scientist Dr. Trevor Bedford receives MacArthur Fellowship
Recognized for research and public health contributions in tracking viral spread and evolution
Matsen, Bedford named Howard Hughes Medical Institute Investigators
Acclaimed computational biologists each awarded 7 years of funding
New open source software empowers scientists to uncover immune secrets
'Infinity Flow’ adds machine learning to widespread, but limited, technology for analyzing single cells
Investment in business development pays dividends for research, patients
Fred Hutch tech transfer specialists help scientists navigate path to bringing innovations to patients
Science Says: Back to the future
Navigating work, school, and well-being in a world transformed by COVID-19
New concerns about coronavirus evolution in immunosuppressed patients
Experts call for tighter precautions, better treatments, more research
How studies of coronavirus immunity can inform better vaccines, treatments
Scientists look for broad-acting antibodies that could protect against new variants of SARS-CoV-2 — and maybe a future SARS-3
College students muster for big COVID-19 vaccine study
12,000 participants sought in study to prove if vaccine can block asymptomatic transmission